sk&f 100330-a has been researched along with clonazepam in 2 studies
| Studies (sk&f 100330-a) | Trials (sk&f 100330-a) | Recent Studies (post-2010) (sk&f 100330-a) | Studies (clonazepam) | Trials (clonazepam) | Recent Studies (post-2010) (clonazepam) |
|---|---|---|---|---|---|
| 20 | 0 | 0 | 2,719 | 239 | 519 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, KE; Braestrup, C; Knutsen, LJ; Nielsen, EB; Sonnewald, U; Suzdak, PD | 1 |
| Bonanno, G; Raiteri, L; Raiteri, M; Stigliani, S; Zedda, L | 1 |
2 other study(ies) available for sk&f 100330-a and clonazepam
| Article | Year |
|---|---|
Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor.
Topics: Animals; Anticonvulsants; Carbolines; Clonazepam; Convulsants; Diazepam; Female; GABA Antagonists; gamma-Aminobutyric Acid; Male; Mice; Mice, Inbred DBA; Neurotransmitter Uptake Inhibitors; Nicotinic Acids; Nipecotic Acids; Pentylenetetrazole; Rats; Rats, Inbred Strains; Seizures; Tiagabine | 1991 |
Multiple mechanisms of transmitter release evoked by "pathologically" elevated extracellular [K+]: involvement of transporter reversal and mitochondrial calcium.
Topics: Animals; Anticonvulsants; Brain Chemistry; Calcium; Carrier Proteins; Cerebral Cortex; Chelating Agents; Clonazepam; Dose-Response Relationship, Drug; Enzyme Inhibitors; Exocytosis; Extracellular Space; Fluorescent Dyes; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Male; Membrane Proteins; Membrane Transport Proteins; Nicotinic Acids; Organic Anion Transporters; Potassium Chloride; Rats; Rats, Sprague-Dawley; Sodium-Calcium Exchanger; Synaptosomes; Thiazepines; Tritium | 2002 |